35
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Late relapse following allogeneic transplant for chronic lymphocytic leukemia: How good are graft versus leukemia effects?

&
Pages 1651-1652 | Published online: 01 Jul 2009

References

  • Keating M J, O'Brien S, Kontoyiannis D, Plunkett W, Koller C, Beran M, et al. Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemia. Leuk Lymphoma 2002; 43: 1755–1762
  • Michallet M, Archimbaud E, Bandini G, Rowlings P A, Deeg H J, Gahrton G, et al. HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry. Ann Intern Med 1996; 124: 311–315
  • Gribben J G. Salvage therapy for CLL and the role of stem cell transplantation. Hematology (Am Soc Hematol Educ Program) 2005; 292–297
  • Malhotra P, Hogan J W, Litzow M R, Elliott M A, Gastineau D A, Ansell S M, et al. Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: Analysis after a minimum follow-up of 5 years. Leuk Lymphoma, in press
  • Dreger P, Corradini P, Kimby E, Michallet M, Milligan D, Schetelig J, et al. Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus. Leukemia 2007; 21: 12–17
  • Moreno C, Villamor N, Colomer D, Esteve J, Martino R, Nomdedéu J, et al. Allogeneic stem-cell transplantation may overcome the adverse prognosis of unmutated VH gene in patients with chronic lymphocytic leukemia. J Clin Oncol 2005; 23: 3433–3438
  • Dreger P, Ritgen M, Böttcher S, Schmitz N, Kneba M. The prognostic impact of minimal residual disease assessment after stem cell transplantation for chronic lymphocytic leukemia: is achievement of molecular remission worthwhile. Leukemia 2005; 19: 1135–1138
  • Schetelig J, Thiede C, Bornhauser M, Schwerdtfeger R, Kiehl M, Beyer J, et al. Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: The Cooperative German Transplant Study Group. J Clin Oncol 2003; 21: 2747–2753
  • Hallek M, Cheson B D, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008; 111;12: 5446–5456
  • Rittgen M, Bottcher S, Stilgenbauer S, Bunjes D, Schubert J, Cohen S, et al. Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial. Leukemia 2008; 22: 1377–1386
  • Cox C V, Evely R S, Oakhill A, Pamphilon D H, Goulden N J, Blair A. Characterization of acute lymphoblastic leukemia progenitor cells. Blood 2004; 104: 2919–2925
  • Huff C A, Matsui W. Multiple myeloma cancer stem cells. J Clin Oncol 2008; 26: 2895–2900

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.